Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Oct 1;15(4):e20255417.
doi: 10.5826/dpc.1504a5417.

Post-COVID Hair Loss in the Indian Subcontinent: Clinical Patterns and Association with Disease Severity

Affiliations

Post-COVID Hair Loss in the Indian Subcontinent: Clinical Patterns and Association with Disease Severity

Anshitha Vurimindi Kadudas et al. Dermatol Pract Concept. .

Abstract

Introduction: As the pandemic plateaus, post-COVID alopecia is resurfacing in India. COVID-19 remains a pivotal cause of alopecia, and the diagnosis of post-COVID alopecia aids in better treatment outcomes.

Objectives: To estimate the prevalence of post-COVID alopecia and to evaluate the association between alopecia and COVID severity among other factors.

Methods: A retrospective cross-sectional study was conducted among patients admitted to the COVID ward. Patients willing to participate were asked to fill in a pretested semi-structured questionnaire, and the PSS-10 (Perceived Stress Scale) was used to evaluate stress. Data were analyzed using the SPSS version 24.

Results: Prevalence of COVID-19-induced hair loss was 37.8%. Age, sex, COVID severity, and higher stress were the significant factors, with p-value <0.05. Female sex, COVID severity, and high stress levels came to be significant independent predictors of hair loss. A majority of participants (46.9%) noticed hair loss within three months of contracting the disease.

Conclusion: This study stands to be a pioneer project to investigate the prevalence of COVID-19-induced alopecia in India. The prevalence rate of 37.8% with a significant association with severity of COVID-19 highlights the importance of reviewing patient history to provide proper treatment and reassurance.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: None.

Figures

Figure 1
Figure 1
Prevalence of alopecia among post COVID patients. This pie chart illustrates the prevalence of hair loss among study participants, showing the percentages with and without hair loss.
Figure 2
Figure 2
Dietary habits of study participants. This figure illustrates the distribution of dietary habits among participants, comparing mixed and vegetarian diets, presented as percentages.
Figure 3
Figure 3
Family history of hair loss. The figure shows the prevalence of hair loss in male and female family members, with data presented as the percentage of participants reporting a family history of hair loss in each group.

References

    1. World Health Organization. WHO COVID-19 Dashboard. [Accessed March 1, 2024]. https://data.who.int/dashboards/covid19/cases?n=c .
    1. Nalbandian A, Sehgal K, Gupta A, et al. Post-acute COVID-19 syndrome. Nat Med. 2021;27:601–615. doi: 10.1038/s41591-021-01283-z. - DOI - PMC - PubMed
    1. Freeman EE, et al. The spectrum of COVID-19-associated dermatologic manifestations: an international registry of 716 patients from 31 countries. J Am Acad Dermatol. 2020 Oct;83(4):1118–1129. doi: 10.1016/j.jaad.2020.06.1016. Epub 2020 Jul 2. - DOI - PMC - PubMed
    1. Abdulwahab RA, et al. Prevalence of hair loss after COVID-19 infection in the Makkah region, Saudi Arabia Cureus 2022Sep18149e29285. 10.7759/cureus.29285 - DOI - PMC - PubMed
    1. Starace M, et al. Trichodynia and telogen effluvium in COVID-19 patients: results of an international expert opinion survey on diagnosis and management. JAAD Int. 2021 Dec;5:11–18. doi: 10.1016/j.jdin.2021.07.006. Epub 2021 Aug 3. - DOI - PMC - PubMed

LinkOut - more resources